Brief: PDS Biotech Provides Business Update And Reports First Quarter 2023 Financial Results
15/05/2023 12:53
May 15 (Reuters) - Pds Biotechnology Corp PDSB.O :
* PDS BIOTECH PROVIDES BUSINESS UPDATE AND REPORTS FIRST
QUARTER
2023 FINANCIAL RESULTS
* QTRLY LOSS PER SHARE $0.32
* CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2023, TOTALED
ABOUT
$65.2 MILLION
* BELIEVES CASH BALANCE IS SUFFICIENT TO FUND CO'S
OPERATIONS AND
RESEARCH AND DEVELOPMENT PROGRAMS INTO Q3 2024
* Q1 EARNINGS PER SHARE VIEW $-0.31 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1ZQ2sR
Further company coverage: PDSB.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on PDS Biotechnology
See all newsPDS Biotechnology Corp reports results for the quarter ended September 30 - Earnings Summary
PDS Biotechnology Q3 net loss narrows on lower R&D costs
PDS Biotechnology Corp expected to post a loss of 10 cents a share - Earnings Preview
Brief: PDS Biotech Announces Initial Closing Of Up To $22.3 Mln PIPE Financing
Brief: Pds Biotechnology Corp - On Aug 6, Approved Reduction In Force To Align Expenses With Strategic Priorities - SEC Filing